Tag Archives: Vaccine development

from www.shutterstock.com Archa Fox, The University of Western Australia and Damian Purcell, The Peter Doherty Institute for Infection and Immunity The world’s first mRNA vaccines — the COVID-19 vaccines from Pfizer/BioNTech and Moderna — have made it in record time from the laboratory, through successful clinical trials, regulatory approval and into people’s arms. The high efficiency of protection against severe …

David Whyte, University of Liverpool Boris Johnson, the UK prime minister, reportedly attributed the success of the COVID-19 vaccines to “capitalism” and “greed”. But he is wrong – the idea that private ingenuity and naked competition produced the vaccines is a complete fantasy. Before COVID-19, the vaccine market was notoriously sluggish, taking between five and 15 years to develop a …

University of Oxford Tonia Thomas, University of Oxford and Rachel Colin-Jones, University of Oxford The pandemic is only a year old, but we already have multiple vaccines available to fight COVID-19 – including the vaccine developed by the team we’re part of at the University of Oxford. With our partner AstraZeneca, we have submitted both interim efficacy data and safety …

Studio Peace/Shutterstock Simon Kolstoe, University of Portsmouth It is very exciting to hear another positive story about vaccine trial results – a good vaccine is the most likely way of ending the pandemic. Last week, interim results from Pfizer suggested its vaccine reduces cases of COVID-19 with 90% efficacy. Now Moderna has gone one better, with interim results showing nearly …

M-Foto/Shutterstock Rob Reddick, The Conversation Since the early days of the pandemic, attention has focused on producing a vaccine for COVID-19. With one, it’s hoped it will be able to suppress the virus without relying purely on economically challenging control measures. Without one, the world will probably have to live with COVID-19 as an endemic disease. It’s unlikely the coronavirus …

A worker inspects vials of a SARS CoV-2 vaccine for COVID-19 produced by SinoVac at its factory in Beijing on Sept. 24, 2020. (AP Photo/Ng Han Guan) Byram W. Bridle, University of Guelph; Samira Mubareka, University of Toronto, and Shayan Sharif, University of Guelph Athletes understand that there are two very different approaches that can be taken when training their …

Rebecca Ashfield, University of Oxford and Pedro Folegatti, University of Oxford Of the hundreds of potential COVID-19 vaccines in development, six are in the final stages of testing, known as phase 3 clinical trials. One of these – ChAdOx1 nCoV-19 – is the vaccine we’re developing at the University of Oxford. To be approved, vaccines need to go through multiple …